Robert J Fox Selected Research

ibudilast

11/2021	Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis.
4/2021	Influence of equipment changes on MRI measures of brain atrophy and brain microstructure in a placebo-controlled trial of ibudilast in progressive multiple sclerosis.
1/2021	Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype.
1/2021	Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study.
1/2021	Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.
10/2019	Vitamin D and MRI measures in progressive multiple sclerosis.
1/2018	Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
1/2016	Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
6/2015	Progressive multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Fox Research Topics

Disease

70	Multiple Sclerosis 06/2022 - 08/2002
29	Relapsing-Remitting Multiple Sclerosis 01/2022 - 02/2008
12	Atrophy 01/2022 - 04/2005
9	Chronic Progressive Multiple Sclerosis 09/2022 - 06/2004
6	Inflammation (Inflammations) 01/2022 - 06/2006
6	Disease Progression 11/2021 - 05/2007
4	Progressive Multifocal Leukoencephalopathy 12/2021 - 06/2013
4	Flushing 03/2017 - 09/2012
3	COVID-19 04/2022 - 01/2021
3	Diarrhea 01/2022 - 05/2016
3	Neuromyelitis Optica (Devic's Disease) 01/2021 - 11/2008
3	Demyelinating Diseases (Demyelinating Disease) 05/2013 - 05/2007
2	Nausea 01/2022 - 03/2017
2	Ganglion Cysts (Ganglion) 03/2021 - 01/2021
2	Abdominal Pain (Pain, Abdominal) 03/2017 - 05/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016 - 02/2013
1	Exanthema (Rash) 01/2022
1	Infections 01/2022
1	Clinical Deterioration 01/2022
1	Fatigue 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Hypertension (High Blood Pressure) 01/2018
1	Headache (Headaches) 01/2018
1	Herpes Zoster 01/2018
1	Chickenpox 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Bradycardia 01/2018
1	Sclerosis 08/2017
1	Vomiting 03/2017
1	Neoplasms (Cancer) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Crohn Disease (Crohn's Disease) 06/2013

Drug/Important Bio-Agent (IBA)

35	Dimethyl FumarateIBA 01/2022 - 09/2012
11	Natalizumab (Tysabri)FDA Link 12/2021 - 02/2012
9	siponimodIBA 09/2022 - 06/2015
9	ibudilastIBA 11/2021 - 06/2015
6	Glatiramer Acetate (Copaxone)FDA Link 11/2021 - 09/2012
5	Rituximab (Mabthera)FDA Link 11/2021 - 02/2008
5	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2006
5	Fingolimod Hydrochloride (FTY720)FDA Link 12/2019 - 11/2016
4	InterferonsIBA 11/2021 - 11/2005
3	ocrelizumabIBA 11/2021 - 06/2015
3	hydroxide ionIBA 03/2021 - 10/2018
3	Retinaldehyde (Retinal)IBA 03/2021 - 01/2016
3	GadoliniumIBA 01/2021 - 11/2010
3	Chemokine ReceptorsIBA 01/2009 - 01/2006
2	Vitamin D FDA LinkGeneric 03/2021 - 10/2019
2	Pharmaceutical PreparationsIBA 01/2016 - 06/2004
2	SteroidsIBA 11/2015 - 05/2007
2	AntibodiesIBA 07/2014 - 12/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2006 - 04/2005
2	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2006 - 06/2004
1	Sphingosine-1-Phosphate ReceptorsIBA 09/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2022
1	COVID-19 VaccinesIBA 04/2022
1	CalciumIBA 01/2022
1	Cytidine Diphosphate (CDP)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Dihydroorotate DehydrogenaseIBA 01/2022
1	vidofludimusIBA 01/2022
1	masitinibIBA 01/2022
1	W 12IBA 01/2022
1	IronIBA 12/2021
1	Cladribine FDA LinkGeneric 11/2021
1	Alemtuzumab (Campath)FDA Link 11/2021
1	EnzymesIBA 01/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021
1	teriflunomideIBA 01/2021
1	ponesimodIBA 01/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021
1	Protons (Proton)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2020
1	25-hydroxyvitamin DIBA 10/2019
1	Calcifediol (Calcidiol)FDA Link 10/2019
1	Myelin ProteinsIBA 10/2018
1	Macrophage Migration-Inhibitory FactorsIBA 01/2018
1	Cyclic NucleotidesIBA 01/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2017
1	Neuroprotective AgentsIBA 06/2016
1	Interferon-betaIBA 05/2016
1	efalizumab (Raptiva)FDA Link 01/2016
1	IntegrinsIBA 01/2016
1	Phosphodiesterase InhibitorsIBA 06/2015
1	Simvastatin (Zocor)FDA LinkGeneric 06/2015
1	N-acetyltalosaminuronic acid (NAT)IBA 05/2015
1	FumaratesIBA 03/2015
1	AMPA Receptors (AMPA Receptor)IBA 05/2013
1	MicroRNAs (MicroRNA)IBA 05/2013

Therapy/Procedure

34	Therapeutics 06/2022 - 08/2002
2	Assisted Suicide (Physician Assisted Suicide) 04/2017 - 01/2017
1	Activities of Daily Living (ADL) 01/2021
1	Precision Medicine 01/2018
1	Mesenchymal Stem Cell Transplantation 01/2018
1	Immunomodulation 01/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2015
1	Complementary Therapies (Alternative Medicine) 03/2014
1	Injections 01/2013